BP000070-CYT-314: Recombinant Human Growth and Differentiation Factor 15 D-Variant
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000070-CYT-691: Recombinant Human Growth and Differentiation Factor 15, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000070-CYT-335: Recombinant Human Growth and Differentiation Factor 15
Source: E. coli-derived.
The biological activity was assessed by the inhibition of DU-145 cells and was found to be 1-2 ug/ml.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000201-CYT-708: Recombinant Human Galectin-9
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.BP000200-CYT-017: Recombinant Human Galectin-8
Source: E. coli-derived.
The ED50 of Galectin-8 as determined by its ability to agglutinate human red blood cells is 0.8~4 ug/ml.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000200-CYT-727: Recombinant Human Galectin-8, His Tag
Source: E. coli-derived.
Purity > 90%, by SDS--PAGE.BP000199-CYT-016: Recombinant Human Galectin-7
Source: E. coli-derived.
The ED50 of Galectin-7 as determined by hemagglutination test is 0.75~3 ug/ml.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000199-CYT-617: Recombinant Human Galectin-7, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000035-HOR-249: Human FSH
Source: Urine of post-menopausal women-derived.BP000045-CYT-409: Recombinant Human Flt3 Ligand, Sf9
Source: Baculovirus Sf9 cells-derived.
The ED50, calculated by the dose-dependant stimulation of the proliferation of human MUTZ-2cells is < 3.0 ug/ml.
Purity > 95%, by SDS-PAGE and RP-HPLC.